Contamination News and Research

RSS

Groton Biosystems releases in-situ filter sampling probe for automated, manual extraction of cell-free samples

Groton Biosystems, the leader in automated online bioprocess sampling, has announced the release of a sterilizable, disposable in-situ filter sampling probe for automated and manual extraction of cell-free samples. The rugged design of this product delivers extended service life in typical bioreactor applications and features a nonbinding inert surface which resists clogging throughout the extended process runtimes most often associated with cell culture and perfusion applications.

30 Jun 2010

Uganda children have high blood lead levels: Researchers

Researchers at Mount Sinai School of Medicine have found that children living near the Kiteezi landfill in Kampala, Uganda, have blood lead levels nearly 20 times as high as the typical lead level found in U.S. children.

30 Jun 2010

'Beeglue' may help deliver new treatments for fatal infections

Bees could have a key role to play in urgently-needed new treatments to fight the virulent MRSA bug, according to research led at the University of Strathclyde in Glasgow, Scotland.

29 Jun 2010

Masimo granted FDA clearance for Pronto-7 noninvasive hemoglobin spot-check testing device

Masimo, the inventor of Masimo Rainbow Pulse CO-Oximetry™, Masimo Rainbow Acoustic Monitoring™, and Masimo SET® Measure-Through Motion and Low Perfusion pulse oximetry, today announced FDA 510(k) clearance for the Pronto-7™—a new handheld device designed for quick and easy noninvasive hemoglobin (SpHb®) spot-check testing, along with SpO2, pulse rate, and perfusion index, in virtually any environment.

28 Jun 2010

Masimo announces limited market release of Pronto-7 handheld hemoglobin spot-check testing device

Masimo, the inventor of Rainbow Pulse CO-Oximetry™, Rainbow Acoustic Monitoring™, and Masimo SET® Measure-Through Motion and Low Perfusion pulse oximetry, today announced the international limited market release of Masimo Pronto-7 -- a new handheld device designed for quick and easy noninvasive hemoglobin (SpHb®) spot-check testing in virtually any environment.

23 Jun 2010

Exposure to chlordecone associated to increased risk of prostate cancer: Researchers

In an article to be published on 21 June 2010 in the Journal of Clinical Oncology, researchers from Inserm (Inserm unit 625 - Research Group on Human and Mammalian Reproduction, University of Rennes 1), the CHU (University Hospital Centre) in Pointe - Pitre (urology department, University of the French West Indies and Guiana) and from the Center for Analytical Research and Technology (University of Li-ge, Belgique), show that exposure to chlordecone (also named Kepone), an organochlorine chemical with well defined estrogenic properties used in the French West Indies until 1993, is associated to a significant increased risk of prostate cancer.

23 Jun 2010

USPTO issues patent related to Derma Sciences' MEDIHONEY Calcium Alginate Dressing

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announces that the U.S. Patent and Trademark Office has issued patent No. 7,714,183 related to the Company's MEDIHONEY Calcium Alginate Dressing.

22 Jun 2010

Antibacterial lab coats to help prevent spread of disease in hospitals

According to the Centers for Disease Control and Prevention, 99,000 people die every year from infections acquired while in hospitals. "The goal in our profession is to help cure you not introduce you to another deadly infection," said Dr. Charles Kinder, Heart Rhythm expert and Director of Heart Rhythm Program at Heart Care Centers of Illinois.

21 Jun 2010

Sosei reaches agreement to acquire 100% of Activus

Sosei Group Corporation, announced today that it has reached an agreement to acquire 100% of Activus Pharma Ltd., a privately-held biopharmaceutical company based in Chiba, Japan.

21 Jun 2010

Study shows effective and efficient methods for producing recombinant proteins

A shift in the life science market has begun to steer cell culture scientists to re-evaluate their use of native transferrin and iron chelators to pursue recombinant alternatives. Transferrin regulates the uptake, transport and utilization of iron for cellular function, increasing cell growth and productivity. Native transferrin found in bovine or human serum has been widely used in cell culture for these added benefits. However, regulatory issues continue to arise with the use of native transferrin due to blood-borne pathogens.

21 Jun 2010

Groundbreaking ceremony for Ravensburg Vetter West facility

A groundbreaking ceremony was held today for Vetter's newest facility, Ravensburg Vetter West. Vetter, a specialist in aseptically pre-filled drug-delivery systems, will build a state-of-the-art high bay warehouse for cold-storage and room-temperature goods. Space will also be dedicated for automatic and manual visual inspection as well as for stability chambers designed to the highest standards.

19 Jun 2010

ACT awarded patent for production processes of RPE cells from hESCs

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that it has been issued U.S. Patent Number 7736896, which is broadly directed to processes developed by ACT scientists for the production of retinal pigment epithelial (RPE) cells from human embryonic stem cells (hESCs).

17 Jun 2010

KCI's Prevena Incision Management System receives FDA clearance

Kinetic Concepts, Inc. announced today it has received 510(k) clearance from the Food and Drug Administration for the Prevena Incision Management System, a negative pressure wound therapy product designed for management of surgically closed incisions. KCI estimates more than three million procedures are performed each year worldwide that could benefit from treatment with the Prevena System, representing a potential global opportunity greater than $1 billion.

16 Jun 2010

Pervasive bacterial presence unique to contaminated drywall identified

RealTime Laboratories, LLC announced today significant new findings regarding pervasive bacterial presence unique to contaminated drywall. RealTime has identified specific bacteria found only in symptomatic drywall and not in normal domestic drywall that are viable, pervasive and produce hydrogen sulfide and reduced sulfur gases under conditions similar to those found in residences.

16 Jun 2010

NOAA, FDA take additional steps to prevent tainted seafood from reaching U.S. market

The National Oceanic and Atmospheric Administration and the U.S. Food and Drug Administration are taking additional steps to enhance inspection measures designed to ensure that seafood from the Gulf of Mexico reaching America's tables is safe to eat.

15 Jun 2010

EC approves Nivestim for prevention of FN

Hospira announced today that the EC has approved Nivestim™ (filgrastim) for the prevention of FN, the most serious haematological toxicity that occurs as a result of cancer chemotherapy. Nivestim now has marketing authorisation in all EU member states. Nivestim is expected to reduce the cost of neutropenia treatment.

10 Jun 2010

PURE Bioscience's anhydrous SDC technology granted US patent

PURE Bioscience today announced that the United States Patent and Trademark Office issued patent number 7,732,486, which covers PURE's anhydrous silver dihydrogen citrate technology.

10 Jun 2010

Video study shows need for new food safety-focused messages, methods targeting food handlers

How safe is the food we get from restaurants, cafeterias and other food-service providers? A new study from North Carolina State University -- the first study to place video cameras in commercial kitchens to see how precisely food handlers followed food-safety guidelines -- discovered that risky practices happen more often than previously thought.

10 Jun 2010

Purdue University researchers develop potential new tool for medical diagnostics, testing food

Researchers at Purdue University have developed a potential new tool for medical diagnostics, testing food and water for contamination, and crime-scene forensics.

9 Jun 2010

FDA should implement risk-based approach to tackle food safety problems: Report

The U.S. Food and Drug Administration's abilities to discover potential threats to food safety and prevent outbreaks of foodborne illness are hampered by impediments to efficient use of its limited resources and a piecemeal approach to gathering and using information on risks, says a new report by the Institute of Medicine and National Research Council.

9 Jun 2010

Contamination News and Research

Groton Biosystems releases in-situ filter sampling probe for automated, manual extraction of cell-free samples

Uganda children have high blood lead levels: Researchers

'Beeglue' may help deliver new treatments for fatal infections

Masimo granted FDA clearance for Pronto-7 noninvasive hemoglobin spot-check testing device

Masimo announces limited market release of Pronto-7 handheld hemoglobin spot-check testing device

Exposure to chlordecone associated to increased risk of prostate cancer: Researchers

USPTO issues patent related to Derma Sciences' MEDIHONEY Calcium Alginate Dressing

Antibacterial lab coats to help prevent spread of disease in hospitals

Sosei reaches agreement to acquire 100% of Activus

Study shows effective and efficient methods for producing recombinant proteins

Groundbreaking ceremony for Ravensburg Vetter West facility

ACT awarded patent for production processes of RPE cells from hESCs

KCI's Prevena Incision Management System receives FDA clearance

Pervasive bacterial presence unique to contaminated drywall identified

NOAA, FDA take additional steps to prevent tainted seafood from reaching U.S. market

EC approves Nivestim for prevention of FN

PURE Bioscience's anhydrous SDC technology granted US patent

Video study shows need for new food safety-focused messages, methods targeting food handlers

Purdue University researchers develop potential new tool for medical diagnostics, testing food

FDA should implement risk-based approach to tackle food safety problems: Report

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News